Compare FINW & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FINW | HYPR |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | 198 | N/A |
| Industry | Commercial Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.4M | 158.8M |
| IPO Year | 2021 | 2021 |
| Metric | FINW | HYPR |
|---|---|---|
| Price | $14.06 | $1.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $1.59 |
| AVG Volume (30 Days) | 17.3K | ★ 758.2K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.51 | ★ 23.21 |
| EPS | ★ 0.20 | N/A |
| Revenue | N/A | ★ $13,563,000.00 |
| Revenue This Year | $160.48 | $50.75 |
| Revenue Next Year | $35.27 | $29.71 |
| P/E Ratio | $70.30 | ★ N/A |
| Revenue Growth | N/A | ★ 5.22 |
| 52 Week Low | $12.82 | $0.68 |
| 52 Week High | $22.49 | $2.22 |
| Indicator | FINW | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 51.64 | 50.43 |
| Support Level | $13.30 | $1.39 |
| Resistance Level | $14.90 | $1.72 |
| Average True Range (ATR) | 0.41 | 0.10 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 63.56 | 35.94 |
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.